<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37626992</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-7737</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>Biology</Title><ISOAbbreviation>Biology (Basel)</ISOAbbreviation></Journal><ArticleTitle>Vascular Dysfunctions Contribute to the Long-Term Cognitive Deficits Following COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1106</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biology12081106</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus and a member of the corona virus family, primarily affecting the upper respiratory system and the lungs. Like many other respiratory viruses, SARS-CoV-2 can spread to other organ systems. Apart from causing diarrhea, another very common but debilitating complication caused by SARS-CoV-2 is neurological symptoms and cognitive difficulties, which occur in up to two thirds of hospitalized COVID-19 patients and range from shortness of concentration and overall declined cognitive speed to executive or memory function impairment. Neuro-cognitive dysfunction and "brain fog" are frequently present in COVID-19 cases, which can last several months after the infection, leading to disruption of daily life. Cumulative evidence suggests that SARS-CoV-2 affects vasculature in the extra-pulmonary systems directly or indirectly, leading to impairment of endothelial function and even multi-organ damage. The post COVID-19 long-lasting neurocognitive impairments have not been studied fully and their underlying mechanism remains elusive. In this review, we summarize the current understanding of the effects of COVID-19 on vascular dysfunction and how vascular dysfunction leads to cognitive impairment in patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shabani</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center for Cerebrovascular Research, University of California (San Francisco), San Francisco, CA 94131, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California (San Francisco), San Francisco, CA 94131, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jialing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of California (San Francisco), San Francisco, CA 94131, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Hua</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-1566-9877</Identifier><AffiliationInfo><Affiliation>Center for Cerebrovascular Research, University of California (San Francisco), San Francisco, CA 94131, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California (San Francisco), San Francisco, CA 94131, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL122774</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS027713</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS112819</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>IK6 BX004600</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL122774</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX003335</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>NS027713</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS102886</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS112819</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biology (Basel)</MedlineTA><NlmUniqueID>101587988</NlmUniqueID><ISSNLinking>2079-7737</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">blood-brain barrier</Keyword><Keyword MajorTopicYN="N">cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">endothelial cells</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuro-inflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37626992</ArticleId><ArticleId IdType="pmc">PMC10451811</ArticleId><ArticleId IdType="doi">10.3390/biology12081106</ArticleId><ArticleId IdType="pii">biology12081106</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garg A., Marji A., Goyal S., Ismail R. A case of COVID-19 with memory impairment and delayed presentation as stroke. Cureus. 2020;12:e10025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450886</ArticleId><ArticleId IdType="pubmed">32864278</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Cristillo V., Cotti Piccinelli S., Zoppi N., Bonzi G., Sattin D., Schiavolin S., Raggi A., Canale A., Gipponi S. Long-term neurological manifestations of COVID-19: Prevalence and predictive factors. Neurol. Sci. 2021;42:4903&#x2013;4907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuinness L., Clarke E.L., Wade R.G. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE. 2020;15:e0234765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7310678</ArticleId><ArticleId IdType="pubmed">32574165</ArticleId></ArticleIdList></Reference><Reference><Citation>Dub&#xe9; M., Le Coupanec A., Wong A.H., Rini J.M., Desforges M., Talbot P.J. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J. Virol. 2018;92:e00404&#x2013;e00418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6096804</ArticleId><ArticleId IdType="pubmed">29925652</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020;6:542&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Raja C.P., Bharathi B., Chandrasekaran C.V., Muruganantham N., Deepak M., Amit A. Phytopharmaceuticals for Brain Health. CRC Press; Boca Raton, FL, USA: 2017. Science behind Usefulness of Bacopa monnieri for Memory and Cognition; pp. 225&#x2013;250.</Citation></Reference><Reference><Citation>Stefano G.B., Ptacek R., Ptackova H., Martin A., Kream R.M. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce &#x2018;brain fog&#x2019;and results in behavioral changes that favor viral survival. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2021;27:e930886-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S., Banasik K., Pedersen O.B., Nissen J., Cantwell L., Schwinn M., Tulstrup M., Westergaard D., Ullum H., Brunak S. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 2021;11:13153. doi: 10.1038/s41598-021-92045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna T.J., Ely E.W., Smith D.M., Langa K.M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787&#x2013;1794. doi: 10.1001/jama.2010.1553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1553</ArticleId><ArticleId IdType="pmc">PMC3345288</ArticleId><ArticleId IdType="pubmed">20978258</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmler A., Widmann C.N., Okulla T., Urbach H., Kaiser M., Widman G., Mormann F., Weide J., Fliessbach K., Hoeft A. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J. Neurol. Neurosurg. Psychiatry. 2013;84:62&#x2013;69. doi: 10.1136/jnnp-2012-302883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302883</ArticleId><ArticleId IdType="pubmed">23134661</ArticleId></ArticleIdList></Reference><Reference><Citation>Penninx B.W.J.H. Psychiatric symptoms and cognitive impairment in &#x201c;Long COVID&#x201d;: The relevance of immunopsychiatry. World Psychiatry. 2021;20:357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8429338</ArticleId><ArticleId IdType="pubmed">34505378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozik V., Reuken P., Utech I., Gramlich J., Stallmach Z., Demeyere N., Rakers F., Schwab M., Stallmach A., Finke K. Subtle cognitive impairments in memory, attention, and executive functioning in patients with post-COVID syndrome and their relationships with clinical variables and subjective complaints. medRxiv. 2022 doi: 10.1101/2022.05.23.22275442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.23.22275442</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Ji M., Yang J. Current understanding of long-term cognitive impairment after sepsis. Front. Immunol. 2022;13:855006. doi: 10.3389/fimmu.2022.855006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.855006</ArticleId><ArticleId IdType="pmc">PMC9120941</ArticleId><ArticleId IdType="pubmed">35603184</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Kofler M., Lindner A., Mahlknecht P., Heim B., Limmert V., Sahanic S., Pizzini A. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur. J. Neurol. 2021;28:3348&#x2013;3359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Ohana M. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F., The COVID-19 BioB Outpatient Clinic Study Group Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J., Barnett T.A., Asken B.M., Kelly J.D., Torres L., Stephens M.L., Greenhouse B., Martin J.N., Chow F.C., Deeks S.G. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J. Neurovirol. 2021;27:191&#x2013;195. doi: 10.1007/s13365-021-00954-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K., Chan D. The emergence of cognitive COVID. World Psychiatry. 2021;20:52. doi: 10.1002/wps.20837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20837</ArticleId><ArticleId IdType="pmc">PMC7801840</ArticleId><ArticleId IdType="pubmed">33432769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Lu S., Chen J., Wei N., Wang D., Lyu H., Shi C., Hu S. The landscape of cognitive function in recovered COVID-19 patients. J. Psychiatr. Res. 2020;129:98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., Okell T., Sheerin F., Xie C., Mahmod M. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Malsy J., P&#xf6;ttgen J., Seddiq Zai S., Ufer F., Hadjilaou A., Schmiedel S., Addo M.M., Gerloff C., Heesen C. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2:fcaa205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V., Singla S., Gupta N., Bharati S.J., Garg R., Pandit A., Vig S., Mishra S., Bhatnagar S. The incidence of anosmia in patients with laboratory-confirmed COVID 19 infection in India: An observational study. J. Anaesthesiol. Clin. Pharmacol. 2021;37:51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8174431</ArticleId><ArticleId IdType="pubmed">34103823</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W.M., Alexopoulos G.S., Fridman C.B., Perlis R.H., Gunning F.M. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;46:2235&#x2013;2240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Villani E.R., Vetrano D.L., Damiano C., Paola A.D., Ulgiati A.M., Martin L., Hirdes J.P., Fratiglioni L., Bernabei R., Onder G. Impact of COVID-19-related lockdown on psychosocial, cognitive, and functional well-being in adults with down syndrome. Front. Psychiatry. 2020;11:578686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7655916</ArticleId><ArticleId IdType="pubmed">33192717</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Liu C., Sun Y., Huang W., Ye K. Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study. Brain Behav. Immun. 2021;91:383&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584518</ArticleId><ArticleId IdType="pubmed">33148439</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers H., van der Hoeven J.G., Corsten S., Janssen I., Ewalds E., Simons K.S., Westerhof B., Rettig T.C., Jacobs C., van Santen S. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA. 2022;327:559&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787680</ArticleId><ArticleId IdType="pubmed">35072716</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto O.H., Wu S., Mera R.M., Costa A.F., Recalde B.Y., Issa N.P. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort. Eur. J. Neurol. 2021;28:3245&#x2013;3253. doi: 10.1111/ene.14775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14775</ArticleId><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo V., Pilotto A., Cotti Piccinelli S., Bonzi G., Canale A., Gipponi S., Bezzi M., Leonardi M., Padovani A., Neuro Covid Next Study Group Premorbid vulnerability and disease severity impact on Long-COVID cognitive impairment. Aging Clin. Exp. Res. 2022;34:257&#x2013;260. doi: 10.1007/s40520-021-02042-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-02042-3</ArticleId><ArticleId IdType="pmc">PMC8747881</ArticleId><ArticleId IdType="pubmed">35014002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparks M.A., Crowley S.D., Gurley S.B., Mirotsou M., Coffman T.M. Classical renin-angiotensin system in kidney physiology. Compr. Physiol. 2014;4:1201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4137912</ArticleId><ArticleId IdType="pubmed">24944035</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabani Z. Demyelination as a result of an immune response in patients with COVID-19. Acta Neurol. Belg. 2021;121:859&#x2013;866. doi: 10.1007/s13760-021-01691-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01691-5</ArticleId><ArticleId IdType="pmc">PMC8088756</ArticleId><ArticleId IdType="pubmed">33934300</ArticleId></ArticleIdList></Reference><Reference><Citation>Doobay M.F., Talman L.S., Obr T.D., Tian X., Davisson R.L., Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2007;292:R373&#x2013;R381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1761128</ArticleId><ArticleId IdType="pubmed">16946085</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host&#x2013;virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020;11:995&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Zhang Y., Wu L., Niu S., Song C., Zhang Z., Lu G., Qiao C., Hu Y., Yuen K.-Y. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181:894&#x2013;904.e9. doi: 10.1016/j.cell.2020.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7144619</ArticleId><ArticleId IdType="pubmed">32275855</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyran M., Takayama K., Uversky V.N., Lundstrom K., Pal&#xf9; G., Sherchan S.P., Attrish D., Rezaei N., Aljabali A.A., Ghosh S. The structural basis of accelerated host cell entry by SARS-CoV-2. FEBS J. 2021;288:5010&#x2013;5020. doi: 10.1111/febs.15651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15651</ArticleId><ArticleId IdType="pmc">PMC7753708</ArticleId><ArticleId IdType="pubmed">33264497</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16&#x2013;27.e1. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J., Randeva H.S., Chatha K., Hall M., Spandidos D.A., Karteris E., Kyrou I. Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol. Med. Rep. 2020;22:4221&#x2013;4226. doi: 10.3892/mmr.2020.11510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11510</ArticleId><ArticleId IdType="pmc">PMC7533503</ArticleId><ArticleId IdType="pubmed">33000221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich H., Pillat M.M. CD147 as a target for COVID-19 treatment: Suggested effects of azithromycin and stem cell engagement. Stem Cell Rev. Rep. 2020;16:434&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167302</ArticleId><ArticleId IdType="pubmed">32307653</ArticleId></ArticleIdList></Reference><Reference><Citation>Istifli E.S., Tepe A.&#x15e;., Sarik&#xdc;rkc&#xdc; C., Tepe B. Interaction of certain monoterpenoid hydrocarbons with the receptor binding domain of 2019 novel coronavirus (2019-nCoV), transmembrane serine protease 2 (TMPRSS2), cathepsin B, and cathepsin L (CatB/L) and their pharmacokinetic properties. Turk. J. Biol. 2020;44:242&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314502</ArticleId><ArticleId IdType="pubmed">32595360</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2020;117:11727&#x2013;11734. doi: 10.1073/pnas.2003138117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabani Z., Schuerger J., Su H. Cellular loci involved in the development of brain arteriovenous malformations. Front. Hum. Neurosci. 2022;16:968369. doi: 10.3389/fnhum.2022.968369.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2022.968369</ArticleId><ArticleId IdType="pmc">PMC9532630</ArticleId><ArticleId IdType="pubmed">36211120</ArticleId></ArticleIdList></Reference><Reference><Citation>Osburn W.O., Smith K., Yanek L., Amat-Alcaron N., Thiemann D.R., Cox A.L., Leucker T.M., Lowenstein C.J. Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19. PLoS ONE. 2022;17:e0268296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9119480</ArticleId><ArticleId IdType="pubmed">35588115</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotoli B.M., Barilli A., Visigalli R., Ferrari F., Dall&#x2019;Asta V. Endothelial cell activation by sars-cov-2 spike s1 protein: A crosstalk between endothelium and innate immune cells. Biomedicines. 2021;9:1220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8470710</ArticleId><ArticleId IdType="pubmed">34572407</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely L., Bozoky B., Bendek M., Ostad M., Lavignasse P., Haag L., Wu J., Jing X., Gupta S., Saccon E. Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death. Heliyon. 2021;7:e07134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141733</ArticleId><ArticleId IdType="pubmed">34056141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatnagar J., Gary J., Reagan-Steiner S., Estetter L.B., Tong S., Tao Y., Denison A.M., Lee E., DeLeon-Carnes M., Li Y. Evidence of severe acute respiratory syndrome coronavirus 2 replication and tropism in the lungs, airways, and vascular endothelium of patients with fatal coronavirus disease 2019: An autopsy case series. J. Infect. Dis. 2021;223:752&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928839</ArticleId><ArticleId IdType="pubmed">33502471</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M., Lely A., Navis G.v., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. A J. Pathol. Soc. Great Br. Irel. 2004;203:631&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Hao G. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. Cardiovasc. Res. 2020;116:1932&#x2013;1936. doi: 10.1093/cvr/cvaa093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa093</ArticleId><ArticleId IdType="pmc">PMC7184394</ArticleId><ArticleId IdType="pubmed">32267499</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Chen W., Zhou Y.-S., Lian J.-Q., Zhang Z., Du P., Gong L., Zhang Y., Cui H.-Y., Geng J.-J. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. 2020 doi: 10.1101/2020.03.14.988345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.14.988345</ArticleId><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U., Zinkernagel A.S., Shambat S.M., Zeng X., Cathomas G., Ruschitzka F., Schuepbach R.A., Moch H., Varga Z. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine. 2021;63:103182. doi: 10.1016/j.ebiom.2020.103182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103182</ArticleId><ArticleId IdType="pmc">PMC7808909</ArticleId><ArticleId IdType="pubmed">33422990</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary S., Kanevsky I., Yildiz S., Sellers R.S., Swanson K.A., Franks T., Rathnasinghe R., Munoz-Moreno R., Jangra S., Gonzalez O. Modeling SARS-CoV-2: Comparative pathology in rhesus macaque and Golden Syrian hamster models. Toxicol. Pathol. 2022;50:280&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8819578</ArticleId><ArticleId IdType="pubmed">35128980</ArticleId></ArticleIdList></Reference><Reference><Citation>Adesse D., Gladulich L., Alvarez-Rosa L., Siqueira M., Marcos A.C., Heider M., Motta C.S., Torices S., Toborek M., Stipursky J. Role of aging in Blood&#x2013;Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: Impacts on neurological symptoms of COVID-19. Fluids Barriers CNS. 2022;19:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9386676</ArticleId><ArticleId IdType="pubmed">35982454</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta C.S., Torices S., da Rosa B.G., Marcos A.C., Alvarez-Rosa L., Siqueira M., Moreno-Rodriguez T., Matos A.d.R., Caetano B.C., Martins J.S.C.d.C. Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-&#x3ba;B Non-Canonical Pathway and Mitochondrial Remodeling. Viruses. 2023;15:745. doi: 10.3390/v15030745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030745</ArticleId><ArticleId IdType="pmc">PMC10056985</ArticleId><ArticleId IdType="pubmed">36992454</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Z., Liu F., Blair R., Wang C., Yang H., Mudd J., Currey J.M., Iwanaga N., He J., Mi R. Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics. 2021;11:8076. doi: 10.7150/thno.61810.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.61810</ArticleId><ArticleId IdType="pmc">PMC8315069</ArticleId><ArticleId IdType="pubmed">34335981</ArticleId></ArticleIdList></Reference><Reference><Citation>Werlein C., Ackermann M., Stark H., Shah H.R., Tzankov A., Haslbauer J.D., von Stillfried S., B&#xfc;low R.D., El-Armouche A., Kuenzel S. Inflammation and vascular remodeling in COVID-19 hearts. Angiogenesis. 2022;26:233&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9660162</ArticleId><ArticleId IdType="pubmed">36371548</ArticleId></ArticleIdList></Reference><Reference><Citation>Potje S.R., Costa T.J., Fraga-Silva T.F., Martins R.B., Benatti M.N., Almado C.E., de Sa K.S., Bonato V.L., Arruda E., Louzada-Junior P. Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients. Life Sci. 2021;276:119376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997864</ArticleId><ArticleId IdType="pubmed">33781826</ArticleId></ArticleIdList></Reference><Reference><Citation>du Preez H.N., Aldous C., Hayden M.R., Kruger H.G., Lin J. Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx. FASEB J. 2022;36:e22052. doi: 10.1096/fj.202101100RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202101100RR</ArticleId><ArticleId IdType="pubmed">34862979</ArticleId></ArticleIdList></Reference><Reference><Citation>Targosz-Korecka M., Kubisiak A., Kloska D., Kopacz A., Grochot-Przeczek A., Szymonski M. Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors. Sci. Rep. 2021;11:12157. doi: 10.1038/s41598-021-91231-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91231-1</ArticleId><ArticleId IdType="pmc">PMC8190434</ArticleId><ArticleId IdType="pubmed">34108510</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollenberg R., Tepasse P.-R., Ochs K., Floer M., Strauss M., Rennebaum F., Kabar I., Rovas A., Nowacki T. Indications of persistent glycocalyx damage in convalescent COVID-19 patients: A prospective multicenter study and hypothesis. Viruses. 2021;13:2324. doi: 10.3390/v13112324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112324</ArticleId><ArticleId IdType="pmc">PMC8619155</ArticleId><ArticleId IdType="pubmed">34835130</ArticleId></ArticleIdList></Reference><Reference><Citation>Langen U.H., Ayloo S., Gu C. Development and cell biology of the blood-brain barrier. Annu. Rev. Cell Dev. Biol. 2019;35:591&#x2013;613. doi: 10.1146/annurev-cellbio-100617-062608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100617-062608</ArticleId><ArticleId IdType="pmc">PMC8934576</ArticleId><ArticleId IdType="pubmed">31299172</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C., Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 2016;4:e1138017. doi: 10.1080/21688370.2015.1138017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21688370.2015.1138017</ArticleId><ArticleId IdType="pmc">PMC4836485</ArticleId><ArticleId IdType="pubmed">27141420</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleau C., Filliol A., Samson M., Lamontagne L. Brain invasion by mouse hepatitis virus depends on impairment of tight junctions and beta interferon production in brain microvascular endothelial cells. J. Virol. 2015;89:9896&#x2013;9908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4577898</ArticleId><ArticleId IdType="pubmed">26202229</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquisiras-Burgos I., Peralta-Arrieta I., Alonso-Palomares L.A., Zacapala-Gomez A.E., Salmeron-Barcenas E.G., Aguilera P. Neurological complications associated with the blood-brain barrier damage induced by the inflammatory response during SARS-CoV-2 infection. Mol. Neurobiol. 2021;58:520&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518400</ArticleId><ArticleId IdType="pubmed">32978729</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R.-C., Huang K., Zhang H.-P., Li L., Zhang Y.-F., Tan C., Chen H.-C., Jin M.-L., Wang X.-R. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J. Neuroinflamm. 2022;19:149. doi: 10.1186/s12974-022-02514-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02514-x</ArticleId><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi M.M., Gong C., Xu Y.G., Chang Y., Shi H. Factors controlling permeability of the blood&#x2013;brain barrier. Cell. Mol. Life Sci. 2016;73:57&#x2013;77. doi: 10.1007/s00018-015-2050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-015-2050-8</ArticleId><ArticleId IdType="pmc">PMC11108286</ArticleId><ArticleId IdType="pubmed">26403789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranaivo H.R., Zunich S.M., Choi N., Hodge J.N., Wainwright M.S. Mild stretch-induced injury increases susceptibility to interleukin-1&#x3b2;-induced release of matrix metalloproteinase-9 from astrocytes. J. Neurotrauma. 2011;28:1757&#x2013;1766. doi: 10.1089/neu.2011.1799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2011.1799</ArticleId><ArticleId IdType="pubmed">21732764</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson M.A., Rhea E.M., Knopp R.C., Banks W.A. Interactions of SARS-CoV-2 with the blood&#x2013;brain barrier. Int. J. Mol. Sci. 2021;22:2681. doi: 10.3390/ijms22052681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052681</ArticleId><ArticleId IdType="pmc">PMC7961671</ArticleId><ArticleId IdType="pubmed">33800954</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauti R., Shahoha M., Leichtmann-Bardoogo Y., Nasser R., Paz E., Tamir R., Miller V., Babich T., Shaked K., Ehrlich A. Effect of SARS-CoV-2 proteins on vascular permeability. Elife. 2021;10:e69314. doi: 10.7554/eLife.69314.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.69314</ArticleId><ArticleId IdType="pmc">PMC8545399</ArticleId><ArticleId IdType="pubmed">34694226</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson M.A., Banks W.A. Neuroimmune axes of the blood&#x2013;brain barriers and blood&#x2013;brain interfaces: Bases for physiological regulation, disease states, and pharmacological interventions. Pharmacol. Rev. 2018;70:278&#x2013;314. doi: 10.1124/pr.117.014647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.117.014647</ArticleId><ArticleId IdType="pmc">PMC5833009</ArticleId><ArticleId IdType="pubmed">29496890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilic E., Kilic U., Wang Y., Bassetti C.L., Marti H.H., Hermann D.M. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF&#x2019;s neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 2006;20:1185. doi: 10.1096/fj.05-4829fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-4829fje</ArticleId><ArticleId IdType="pubmed">16641198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S.J., Feigen C.M., Vazquez J.P., Kobets A.J., Altschul D.J. Neurological sequelae of COVID-19. J. Integr. Neurosci. 2022;21:77. doi: 10.31083/j.jin2103077.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2103077</ArticleId><ArticleId IdType="pubmed">35633158</ArticleId></ArticleIdList></Reference><Reference><Citation>Staekenborg S.S., Van der Flier W.M., Van Straaten E.C., Lane R., Barkhof F., Scheltens P. Neurological signs in relation to type of cerebrovascular disease in vascular dementia. Stroke. 2008;39:317&#x2013;322. doi: 10.1161/STROKEAHA.107.493353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.107.493353</ArticleId><ArticleId IdType="pubmed">18096841</ArticleId></ArticleIdList></Reference><Reference><Citation>Miners S., Kehoe P.G., Love S. Cognitive impact of COVID-19: Looking beyond the short term. Alzheimer&#x2019;s Res. Ther. 2020;12:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7772800</ArticleId><ArticleId IdType="pubmed">33380345</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo J., Spittle D.A., Newnham M. COVID-19, immunothrombosis and venous thromboembolism: Biological mechanisms. Thorax. 2021;76:412&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C., Mulvey J.J., Berlin D., Nuovo G., Salvatore S., Harp J., Baxter-Stoltzfus A., Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl. Res. 2020;220:170. doi: 10.1016/j.trsl.2020.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7158248</ArticleId><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Yalavarthi S., Shi H., Gockman K., Zuo M., Madison J.A., Blair C., Weber A., Barnes B.J., Egeblad M. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5:e138999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris A.G., Skalak T.C. Leukocyte cytoskeletal structure determines capillary plugging and network resistance. Am. J. Physiol.-Heart Circ. Physiol. 1993;265:H1670&#x2013;H1675. doi: 10.1152/ajpheart.1993.265.5.H1670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1993.265.5.H1670</ArticleId><ArticleId IdType="pubmed">8238578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz Hern&#xe1;ndez J.C., Bracko O., Kersbergen C.J., Muse V., Haft-Javaherian M., Berg M., Park L., Vinarcsik L.K., Ivasyk I., Rivera D.A. Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer&#x2019;s disease mouse models. Nat. Neurosci. 2019;22:413&#x2013;420. doi: 10.1038/s41593-018-0329-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0329-4</ArticleId><ArticleId IdType="pmc">PMC6508667</ArticleId><ArticleId IdType="pubmed">30742116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Cao C., Chen Z., Bankaitis V., Tzima E., Sheibani N., Burridge K. Pericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammation. PLoS ONE. 2012;7:e45499. doi: 10.1371/journal.pone.0045499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045499</ArticleId><ArticleId IdType="pmc">PMC3448630</ArticleId><ArticleId IdType="pubmed">23029055</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul R., Zhang Z.G., Eliceiri B.P., Jiang Q., Boccia A.D., Zhang R.L., Chopp M., Cheresh D.A. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat. Med. 2001;7:222&#x2013;227. doi: 10.1038/84675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/84675</ArticleId><ArticleId IdType="pubmed">11175854</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D.Z., Ander B.P., Xu H., Shen Y., Kaur P., Deng W., Sharp F.R. Blood&#x2013;brain barrier breakdown and repair by Src after thrombin-induced injury. Ann. Neurol. 2010;67:526&#x2013;533. doi: 10.1002/ana.21924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21924</ArticleId><ArticleId IdType="pmc">PMC2919346</ArticleId><ArticleId IdType="pubmed">20437588</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi N., Roberts A.M., Dean W.L., Tyagi S.C., Lominadze D. Fibrinogen induces endothelial cell permeability. Mol. Cell. Biochem. 2008;307:13&#x2013;22. doi: 10.1007/s11010-007-9579-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-007-9579-2</ArticleId><ArticleId IdType="pmc">PMC2811266</ArticleId><ArticleId IdType="pubmed">17849175</ArticleId></ArticleIdList></Reference><Reference><Citation>Trepat X., Grabulosa M., Buscemi L., Rico F., Farr&#xe9; R., Navajas D. Thrombin and histamine induce stiffening of alveolar epithelial cells. J. Appl. Physiol. 2005;98:1567&#x2013;1574. doi: 10.1152/japplphysiol.00925.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00925.2004</ArticleId><ArticleId IdType="pubmed">15557012</ArticleId></ArticleIdList></Reference><Reference><Citation>Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., Lawrence D.A. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor&#x2013;related protein. J. Clin. Investig. 2003;112:1533&#x2013;1540. doi: 10.1172/JCI200319212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200319212</ArticleId><ArticleId IdType="pmc">PMC259131</ArticleId><ArticleId IdType="pubmed">14617754</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammas P., Samany P.G., Thirumangalakudi L. Thrombin and inflammatory proteins are elevated in Alzheimer&#x2019;s disease microvessels: Implications for disease pathogenesis. J. Alzheimer&#x2019;s Dis. 2006;9:51&#x2013;58. doi: 10.3233/JAD-2006-9105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2006-9105</ArticleId><ArticleId IdType="pubmed">16627934</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah F.A., Pike F., Alvarez K., Angus D., Newman A.B., Lopez O., Tate J., Kapur V., Wilsdon A., Krishnan J.A. Bidirectional relationship between cognitive function and pneumonia. Am. J. Respir. Crit. Care Med. 2013;188:586&#x2013;592. doi: 10.1164/rccm.201212-2154OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201212-2154OC</ArticleId><ArticleId IdType="pmc">PMC3827700</ArticleId><ArticleId IdType="pubmed">23848267</ArticleId></ArticleIdList></Reference><Reference><Citation>Salive M.E., Satterfield S., Ostfeld A.M., Wallace R.B., Havlik R.J. Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults. Public Health Rep. 1993;108:314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1403382</ArticleId><ArticleId IdType="pubmed">8497569</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge M.S., Moss M., Hough C.L., Hopkins R.O., Rice T.W., Bienvenu O.J., Azoulay E. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med. 2016;42:725&#x2013;738. doi: 10.1007/s00134-016-4321-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4321-8</ArticleId><ArticleId IdType="pubmed">27025938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins R.O., Jackson J.C. Long-term neurocognitive function after critical illness. Chest. 2006;130:869&#x2013;878. doi: 10.1378/chest.130.3.869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.130.3.869</ArticleId><ArticleId IdType="pubmed">16963688</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate J.A., Snitz B.E., Alvarez K.A., Nahin R.L., Weissfeld L.A., Lopez O., Angus D.C., Shah F., Ives D.G., Fitzpatrick A.L. Infection hospitalization increases risk of dementia in the elderly. Crit. Care Med. 2014;42:1037. doi: 10.1097/CCM.0000000000000123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000123</ArticleId><ArticleId IdType="pmc">PMC4071960</ArticleId><ArticleId IdType="pubmed">24368344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox M.E., Brummel N.E., Archer K., Ely E.W., Jackson J.C., Hopkins R.O. Cognitive dysfunction in ICU patients: Risk factors, predictors, and rehabilitation interventions. Crit. Care Med. 2013;41:S81&#x2013;S98. doi: 10.1097/CCM.0b013e3182a16946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3182a16946</ArticleId><ArticleId IdType="pubmed">23989098</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervos-Navarro J., Diemer N. Selective vulnerability in brain hypoxia. Crit. Rev. Neurobiol. 1991;6:149&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">1773451</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: Mechanisms in search of treatments. Neuron. 2010;67:181&#x2013;198. doi: 10.1016/j.neuron.2010.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.002</ArticleId><ArticleId IdType="pmc">PMC2957363</ArticleId><ArticleId IdType="pubmed">20670828</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando M.S., Simpson J.E., Matthews F., Brayne C., Lewis C.E., Barber R., Kalaria R.N., Forster G., Esteves F., Wharton S.B. White matter lesions in an unselected cohort of the elderly: Molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37:1391&#x2013;1398. doi: 10.1161/01.STR.0000221308.94473.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000221308.94473.14</ArticleId><ArticleId IdType="pubmed">16627790</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Rosenberg G.A. Blood&#x2013;brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42:3323&#x2013;3328. doi: 10.1161/STROKEAHA.110.608257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.608257</ArticleId><ArticleId IdType="pmc">PMC3584169</ArticleId><ArticleId IdType="pubmed">21940972</ArticleId></ArticleIdList></Reference><Reference><Citation>Esch T., Stefano G.B., Ptacek R., Kream R.M. Emerging roles of blood-borne intact and respiring mitochondria as bidirectional mediators of pro-and anti-inflammatory processes. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2020;26:e924331&#x2013;e924337. doi: 10.12659/MSM.924337.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.924337</ArticleId><ArticleId IdType="pmc">PMC7142321</ArticleId><ArticleId IdType="pubmed">32225126</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy S. Coronavirus (Covid-19) sepsis: Revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality. Inflamm. Res. 2020;69:1077&#x2013;1085. doi: 10.1007/s00011-020-01389-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01389-z</ArticleId><ArticleId IdType="pmc">PMC7410962</ArticleId><ArticleId IdType="pubmed">32767095</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K.K., Chaubey G., Chen J.Y., Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol.-Cell Physiol. 2020;319:C258&#x2013;C267. doi: 10.1152/ajpcell.00224.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Ptacek R., Ptackova H., Martin A., Stefano G.B. Psychiatric manifestations of COVID-19 and their social significance. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2020;26:e930340&#x2013;e930341. doi: 10.12659/MSM.930340.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.930340</ArticleId><ArticleId IdType="pmc">PMC7751254</ArticleId><ArticleId IdType="pubmed">33323916</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostanc&#x131;kl&#x131;o&#x11f;lu M. SARS-CoV2 entry and spread in the lymphatic drainage system of the brain. Brain Behav. Immun. 2020;87:122. doi: 10.1016/j.bbi.2020.04.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.080</ArticleId><ArticleId IdType="pmc">PMC7189839</ArticleId><ArticleId IdType="pubmed">32360606</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L., Steardo Jr L., Zorec R., Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol. 2020;229:e13473. doi: 10.1111/apha.13473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.13473</ArticleId><ArticleId IdType="pmc">PMC7228251</ArticleId><ArticleId IdType="pubmed">32223077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellon M., Schweblin C., Lambeng N., Cherpillod P., Vazquez J., Lalive P.H., Schibler M., Deffert C. Cerebrospinal fluid features in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription polymerase chain reaction (RT-PCR) positive patients. Clin. Infect. Dis. 2021;73:e3102&#x2013;e3105. doi: 10.1093/cid/ciaa1165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1165</ArticleId><ArticleId IdType="pmc">PMC7454353</ArticleId><ArticleId IdType="pubmed">32770235</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng J., Wang L., Zhang L., Qin C., Song Y., Ma Y., Chen Y., Chen S., Wang Y., Zhang Z. Blood-brain barrier disruption induced cognitive impairment is associated with increase of inflammatory cytokine. Front. Aging Neurosci. 2018;10:129. doi: 10.3389/fnagi.2018.00129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00129</ArticleId><ArticleId IdType="pmc">PMC5949351</ArticleId><ArticleId IdType="pubmed">29867440</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A., Nation D.A., Sagare A.P., Barisano G., Sweeney M.D., Chakhoyan A., Pachicano M., Joe E., Nelson A.R., D&#x2019;Orazio L.M., et al. APOE4 leads to blood&#x2013;brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71&#x2013;76. doi: 10.1038/s41586-020-2247-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2247-3</ArticleId><ArticleId IdType="pmc">PMC7250000</ArticleId><ArticleId IdType="pubmed">32376954</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel P.S., Donohue M.C., Sperling R., Hansson O., Mattsson-Carlgren N. The A4 study: &#x3b2;-amyloid and cognition in 4432 cognitively unimpaired adults. Ann. Clin. Transl. Neurol. 2020;7:776&#x2013;785. doi: 10.1002/acn3.51048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51048</ArticleId><ArticleId IdType="pmc">PMC7261742</ArticleId><ArticleId IdType="pubmed">32315118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma G., Zhang D.-F., Zou Q.-C., Xie X., Xu L., Feng X.-L., Li X., Han J.-B., Yu D., Deng Z.-H., et al. SARS-CoV-2 Spike protein S2 subunit modulates &#x3b3;-secretase and enhances amyloid-&#x3b2; production in COVID-19 neuropathy. Cell Discov. 2022;8:99. doi: 10.1038/s41421-022-00458-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-022-00458-3</ArticleId><ArticleId IdType="pmc">PMC9524330</ArticleId><ArticleId IdType="pubmed">36180433</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W.-B., Elahi M., Logue J., Yang P., Baracco L., Reece E.A., Wang B., Li L., Blanchard T.G., Han Z., et al. SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer&#x2019;s-like neuropathology. BioRxiv. 2022 doi: 10.1101/2022.01.31.478476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.31.478476</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasek M.J., Garber C., Dorsey D., Durrant D.M., Bollman B., Soung A., Yu J., Perez-Torres C., Frouin A., Wilton D.K., et al. A complement&#x2013;microglial axis drives synapse loss during virus-induced memory impairment. Nature. 2016;534:538&#x2013;543. doi: 10.1038/nature18283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18283</ArticleId><ArticleId IdType="pmc">PMC5452615</ArticleId><ArticleId IdType="pubmed">27337340</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate G., Memo M., Uberti D. Impact of COVID-19 on Alzheimer&#x2019;s disease risk: Viewpoint for research action. MDPI. 2020;8:286. doi: 10.3390/healthcare8030286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8030286</ArticleId><ArticleId IdType="pmc">PMC7551579</ArticleId><ArticleId IdType="pubmed">32839380</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A.B., Tsilioni I., Leeman S.E., Theoharides T.C. Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism. Proc. Natl. Acad. Sci. USA. 2016;113:E7049&#x2013;E7058. doi: 10.1073/pnas.1604992113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1604992113</ArticleId><ArticleId IdType="pmc">PMC5111711</ArticleId><ArticleId IdType="pubmed">27663735</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Kempuraj D. Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID. Cells. 2023;12:688. doi: 10.3390/cells12050688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050688</ArticleId><ArticleId IdType="pmc">PMC10001285</ArticleId><ArticleId IdType="pubmed">36899824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L., Liu C., Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwar M.M. Immunotherapies and COVID-19 related neurological manifestations: A comprehensive review article. J. Immunoass. Immunochem. 2020;41:960&#x2013;975. doi: 10.1080/15321819.2020.1865400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819.2020.1865400</ArticleId><ArticleId IdType="pubmed">33393415</ArticleId></ArticleIdList></Reference><Reference><Citation>Alnefeesi Y., Siegel A., Lui L.M., Teopiz K.M., Ho R., Lee Y., Nasri F., Gill H., Lin K., Cao B. Impact of SARS-CoV-2 infection on cognitive function: A systematic review. Front. Psychiatry. 2021;11:1629. doi: 10.3389/fpsyt.2020.621773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.621773</ArticleId><ArticleId IdType="pmc">PMC7902710</ArticleId><ArticleId IdType="pubmed">33643083</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W., Li Y., Zhang T., Lu J., Pan J., Qi Q., Dong S., Chen X., Su Z., Li J. Systematic analysis of chemokines reveals CCL18 is a prognostic biomarker in glioblastoma. J. Inflamm. Res. 2022;15:2731&#x2013;2743. doi: 10.2147/JIR.S357787.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S357787</ArticleId><ArticleId IdType="pmc">PMC9059990</ArticleId><ArticleId IdType="pubmed">35509325</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolodziej A., Schulz S., Guyon A., Wu D.-F., Pfeiffer M., Odemis V., H&#xf6;llt V., Stumm R. Tonic activation of CXC chemokine receptor 4 in immature granule cells supports neurogenesis in the adult dentate gyrus. J. Neurosci. 2008;28:4488&#x2013;4500. doi: 10.1523/JNEUROSCI.4721-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4721-07.2008</ArticleId><ArticleId IdType="pmc">PMC6670965</ArticleId><ArticleId IdType="pubmed">18434527</ArticleId></ArticleIdList></Reference><Reference><Citation>Senf K., Karius J., Stumm R., Neuhaus E.M. Chemokine signaling is required for homeostatic and injury-induced neurogenesis in the olfactory epithelium. Stem Cells. 2021;39:617&#x2013;635. doi: 10.1002/stem.3338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.3338</ArticleId><ArticleId IdType="pubmed">33470495</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimabad M.N., Hassanshahi G., Kounis N.G., Mplani V., Roditis P., Gogos C., Lagadinou M., Assimakopoulos S.F., Dousdampanis P., Koniari I. The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses. Vaccines. 2022;10:1299. doi: 10.3390/vaccines10081299.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10081299</ArticleId><ArticleId IdType="pmc">PMC9416781</ArticleId><ArticleId IdType="pubmed">36016187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasui H., Kajiyama H., Tamauchi S., Suzuki S., Peng Y., Yoshikawa N., Sugiyama M., Nakamura K., Kikkawa F. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway. Clin. Exp. Metastasis. 2020;37:145&#x2013;158. doi: 10.1007/s10585-019-09993-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10585-019-09993-y</ArticleId><ArticleId IdType="pubmed">31541326</ArticleId></ArticleIdList></Reference><Reference><Citation>Parajuli B., Horiuchi H., Mizuno T., Takeuchi H., Suzumura A. CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia. Glia. 2015;63:2274&#x2013;2284. doi: 10.1002/glia.22892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22892</ArticleId><ArticleId IdType="pubmed">26184677</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda S.A., Luo J., Mosher K.I., Zou B., Britschgi M., Bieri G., Stan T.M., Fainberg N., Ding Z., Eggel A. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477:90&#x2013;94. doi: 10.1038/nature10357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10357</ArticleId><ArticleId IdType="pmc">PMC3170097</ArticleId><ArticleId IdType="pubmed">21886162</ArticleId></ArticleIdList></Reference><Reference><Citation>Minton K. Mechanistic insights into Long COVID in hamsters. Nat. Rev. Immunol. 2022;22:463. doi: 10.1038/s41577-022-00757-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00757-6</ArticleId><ArticleId IdType="pmc">PMC9244106</ArticleId><ArticleId IdType="pubmed">35768516</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S., Lee E.E., Martin A.S., Soontornniyomkij B., Soontornniyomkij V., Achim C.L., Reuter C., Irwin M.R., Eyler L.T., Jeste D.V. Abnormalities in chemokine levels in schizophrenia and their clinical correlates. Schizophr. Res. 2017;181:63&#x2013;69. doi: 10.1016/j.schres.2016.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2016.09.019</ArticleId><ArticleId IdType="pmc">PMC5357211</ArticleId><ArticleId IdType="pubmed">27650194</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.-H., Wood J., Yal&#xe7;&#x131;n B., Taylor K.R., Dutton S., Acosta-Alvarez L. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv. 2022 doi: 10.1101/2022.01.07.475453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Dong H., Qian Q., Zhang X., Wang Y., Jin W., Qian Y. Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation. Behav. Brain Res. 2017;332:145&#x2013;153. doi: 10.1016/j.bbr.2017.05.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2017.05.066</ArticleId><ArticleId IdType="pubmed">28587818</ArticleId></ArticleIdList></Reference><Reference><Citation>Thirumangalakudi L., Samany P.G., Owoso A., Wiskar B., Grammas P. Angiogenic proteins are expressed by brain blood vessels in Alzheimer&#x2019;s disease. J. Alzheimer&#x2019;s Dis. 2006;10:111&#x2013;118. doi: 10.3233/JAD-2006-10114.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2006-10114</ArticleId><ArticleId IdType="pubmed">16988487</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen L.-A., Geldhof V., Pasut A., Carmeliet P. COVID-19: The vasculature unleashed. Nat. Rev. Immunol. 2020;20:389&#x2013;391. doi: 10.1038/s41577-020-0343-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0343-0</ArticleId><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>